Published in Pharma Investments, Ventures and Law Weekly, March 14th, 2004
Net earnings for the fourth quarter of 2003 increased 57.5% to $133.9 million, or $0.43 per share on a diluted basis, compared to $85.0 million, or $0.26 per share, for the fourth quarter of 2002.
For the full year 2003, Alcon reported global sales of $3,406.9 million, an increase of 13.2% over global sales of $3,009.1 million for the full year 2002, or 9.0% excluding the impact of foreign exchange fluctuations. Net earnings for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.